Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Efficacy

Recent Highlights

Single COVID-19 vaccine shot 96.6% effective in preventing death, two doses 97.5%, says ICMR

Single COVID-19 vaccine shot 96.6% effective in preventing death, two doses 97.5%, says ICMR

.
AstraZeneca's vaccine effectiveness against COIVD-19 lasts longer than Pfizer's finds study

AstraZeneca's vaccine effectiveness against COIVD-19 lasts longer than Pfizer's finds study

.
CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy

CureVac’s COVID-19 mRNA vaccine disappoints in preliminary results as it shows 47 percent efficacy

.
Which is the best COVID-19 vaccine? Is there a right answer to this question?

Which is the best COVID-19 vaccine? Is there a right answer to this question?

.

All Stories for Efficacy

All (8)
  • Opened vial of insulin can be stored for four weeks in warm temperatures, without loosing efficacy

    Opened vial of insulin can be stored for four weeks in warm temperatures, without loosing efficacy

    • .

    Research found that the insulin preparations recorded a potency loss of no more than one percent — the same as in a control batch kept in cold storage.

  • Russia's COVID-19 vaccine successfully completes first phase of human clinical trials

    Russia's COVID-19 vaccine successfully completes first phase of human clinical trials

    Tech2 News Staff • .

    The vaccine is being developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology along with the Russian Defence Ministry.

  • Researchers debate if infecting people on purpose to test Coronavirus vaccines is ethical

    Researchers debate if infecting people on purpose to test Coronavirus vaccines is ethical

    • .

    Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.

  • China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness

    China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness

    • .

    The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.

  • Home
  • efficacy

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV